1. Wu L^#, Tan S^#, Yan Y^#, Zhu L^#, Wu Z, Liu Z, Cheng Q, Qu Q, Li X, Zhang Q, Liu J, Chang J*, Liu R*, Yang S*. “Bifunctional halloysite nanotube-based Ripk1 siRNA delivery system rescues cognitive impairment by targeting amyloid β plaques for clearance and reducing necrotic neurons in Alzheimer’s disease mice.” Chemical Engineering Journal, no. 495 (2024) 153460.

2. Tan S^#, Wu L^#, Liu J^#, Wu Z, Cheng Q. Qu Q, Zhu L, Yan Y, Wu H, Ling T, Liu R*, Yang S*. “Quercetin-3-O-glc-1-3-rham-1-6-glucosidedecreases Aβ production, inhibits Aβ aggregation and neurotoxicity, and prohibits the production of inflammatory cytokines.” European Journal of Pharmacology, no. 970 (2024):176491.

3. Liu S^#, Fu Y^#, Mei K, Jiang Y, Sun X, Wang Y, Ren F, Jiang C, Meng L, Lu S, Qin Z, Dong C, Wang X, Chang Z*, Yang S*. A Shedding Soluble Form of Interleukin-17 Receptor D Exacerbates Collagen-Induced Arthritis through Facilitating TNF-α-dependent Receptor Clustering. Cell. Mol. Immunol., 2020，DOI: 10.1038/s1423-020-00548-w.

4. Yang S^#, Liu W^#, Lu S^#, Tian Y, Wang W*, Ling T*, Liu R*. A novel multifunctional compound Camellikaempferoside B decreases Aβ production, interferes with Aβ aggregation, and prohibits Aβ-mediated neurotoxicity and neuroinflammation. ACS Chem. Neurosci. 7, no. 4 (2016): 505-518.
 5. Yang S^#, Wang Y^#, Mei K, Zhang S, Sun X, Ren F, Liu S, Yang Z, Wang X, Qin Z, Chang Z*. Tumor necrosis factor receptor 2 (TNFR2)· interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism f NF-κB activation. J. Biol. Chem. 290, no. 2 (2015): 861-871.

(#，共同第一作者，*，共同通讯作者)